Market Cap

$609.0M

Volume

1.8M

Cash and Equivalents

$81.5M

EBITDA

-$192.1M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$96.6M

Profit Margin

38.44%

52 Week High

$9.74

52 Week Low

$2.30

Dividend

N/A

Price / Book Value

-4.69

Price / Earnings

-1.76

Price / Tangible Book Value

-4.42

Enterprise Value

$868.4M

Enterprise Value / EBITDA

-4.88

Operating Income

-$199.0M

Return on Equity

591.23%

Return on Assets

-22.77

Cash and Short Term Investments

$232.2M

Debt

$491.6M

Equity

-$129.7M

Revenue

$251.2M

Unlevered FCF

-$140.6M

Sector

Pharmaceuticals

Category

N/A